Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability.

Saved in:
Bibliographic Details
Title: Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability.
Authors: McCloskey EV; Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK. E.V.McCloskey@sheffield.ac.uk.; Metabolic Bone Centre, Sorby Wing, Northern General Hospital, Herries Road, Sheffield, S57AU, UK. E.V.McCloskey@sheffield.ac.uk., Fitzpatrick LA; Radius Health, Inc., Waltham, MA, USA., Hu MY; Radius Health, Inc., Waltham, MA, USA., Williams G; Radius Health, Inc., Waltham, MA, USA., Kanis JA; Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.
Source: Archives of osteoporosis [Arch Osteoporos] 2019 Feb 05; Vol. 14 (1), pp. 15. Date of Electronic Publication: 2019 Feb 05.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Country of Publication: England NLM ID: 101318988 Publication Model: Electronic Cited Medium: Internet ISSN: 1862-3514 (Electronic) NLM ISO Abbreviation: Arch Osteoporos Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1862-3514
DOI:10.1007/s11657-019-0564-7